Artificial Intelligence based Autonomous Molecular Design for Medical Therapeutic: A Perspective

• URL: http://arxiv.org/abs/2102.06045v1
• Date: Wed, 10 Feb 2021 00:43:46 GMT
• Title: Artificial Intelligence based Autonomous Molecular Design for Medical Therapeutic: A Perspective
• Authors: Rajendra P. Joshi and Neeraj Kumar
• Abstract summary: Domain-aware machine learning (ML) models have been increasingly adopted for accelerating small molecule therapeutic design. We present the most recent breakthrough achieved by each of the components, and how such autonomous AI and ML workflow can be realized.
• Score: 9.371378627575883
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Domain-aware machine learning (ML) models have been increasingly adopted for accelerating small molecule therapeutic design in the recent years. These models have been enabled by significant advancement in state-of-the-art artificial intelligence (AI) and computing infrastructures. Several ML architectures are pre-dominantly and independently used either for predicting the properties of small molecules, or for generating lead therapeutic candidates. Synergetically using these individual components along with robust representation and data generation techniques autonomously in closed loops holds enormous promise for accelerated drug design which is a time consuming and expensive task otherwise. In this perspective, we present the most recent breakthrough achieved by each of the components, and how such autonomous AI and ML workflow can be realized to radically accelerate the hit identification and lead optimization. Taken together, this could significantly shorten the timeline for end-to-end antiviral discovery and optimization times to weeks upon the arrival of a novel zoonotic transmission event. Our perspective serves as a guide for researchers to practice autonomous molecular design in therapeutic discovery.

Related papers

• Optimizing Drug Design by Merging Generative AI With Active Learning Frameworks [2.6062146828550903]
  We have developed a Generative AI (GM) workflow based on a variational autoencoder and active learning steps. The designed GM workflow iteratively learns from molecular metrics, including drug likeliness, synthesizability, similarity, and docking scores. The proportion of high-affinity molecules inferred by our GM workflow was significantly greater than that in the training data.
  arXiv  Detail & Related papers  (2023-05-04T13:25:14Z)
• Generating synthetic multi-dimensional molecular-mediator time series data for artificial intelligence-based disease trajectory forecasting and drug development digital twins: Considerations [0.0]
  The use of synthetic data is recognized as a crucial step in the development of neural network-based Artificial Intelligence (AI) systems. Insufficiency of statistical and data-centric machine learning means of generating this type of synthetic data is due to a combination of factors. The generation of synthetic data that accounts for the identified factors of multi-dimensional time series data is an essential capability for the development of mediator-biomarker based AI forecasting systems.
  arXiv  Detail & Related papers  (2023-03-16T03:13:53Z)
• Implicit Geometry and Interaction Embeddings Improve Few-Shot Molecular Property Prediction [53.06671763877109]
  We develop molecular embeddings that encode complex molecular characteristics to improve the performance of few-shot molecular property prediction. Our approach leverages large amounts of synthetic data, namely the results of molecular docking calculations. On multiple molecular property prediction benchmarks, training from the embedding space substantially improves Multi-Task, MAML, and Prototypical Network few-shot learning performance.
  arXiv  Detail & Related papers  (2023-02-04T01:32:40Z)
• Robotic Navigation Autonomy for Subretinal Injection via Intelligent Real-Time Virtual iOCT Volume Slicing [88.99939660183881]
  We propose a framework for autonomous robotic navigation for subretinal injection. Our method consists of an instrument pose estimation method, an online registration between the robotic and the i OCT system, and trajectory planning tailored for navigation to an injection target. Our experiments on ex-vivo porcine eyes demonstrate the precision and repeatability of the method.
  arXiv  Detail & Related papers  (2023-01-17T21:41:21Z)
• Retrieval-based Controllable Molecule Generation [63.44583084888342]
  We propose a new retrieval-based framework for controllable molecule generation. We use a small set of molecules to steer the pre-trained generative model towards synthesizing molecules that satisfy the given design criteria. Our approach is agnostic to the choice of generative models and requires no task-specific fine-tuning.
  arXiv  Detail & Related papers  (2022-08-23T17:01:16Z)
• Generative Enriched Sequential Learning (ESL) Approach for Molecular Design via Augmented Domain Knowledge [1.4410716345002657]
  generative machine learning techniques can generate novel chemical structures based on molecular fingerprint representation. Lack of supervised domain knowledge can mislead the learning procedure to be relatively biased to the prevalent molecules observed in the training data. We alleviated this drawback by augmenting the training data with domain knowledge, e.g. quantitative estimates of the drug-likeness score (QEDs)
  arXiv  Detail & Related papers  (2022-04-05T20:16:11Z)
• Molecule Generation from Input-Attributions over Graph Convolutional Networks [4.468952886990851]
  We present an automatic process which involves Graph Convolutional Network models and input-attribution methods to generate new molecules. We also explore the problems of over-optimization and applicability, recognizing them as two important aspects in the practical use of such automatic tools.
  arXiv  Detail & Related papers  (2022-01-25T09:13:26Z)
• Molecular Attributes Transfer from Non-Parallel Data [57.010952598634944]
  We formulate molecular optimization as a style transfer problem and present a novel generative model that could automatically learn internal differences between two groups of non-parallel data. Experiments on two molecular optimization tasks, toxicity modification and synthesizability improvement, demonstrate that our model significantly outperforms several state-of-the-art methods.
  arXiv  Detail & Related papers  (2021-11-30T06:10:22Z)
• Towards an Automatic Analysis of CHO-K1 Suspension Growth in Microfluidic Single-cell Cultivation [63.94623495501023]
  We propose a novel Machine Learning architecture, which allows us to infuse a neural deep network with human-powered abstraction on the level of data. Specifically, we train a generative model simultaneously on natural and synthetic data, so that it learns a shared representation, from which a target variable, such as the cell count, can be reliably estimated.
  arXiv  Detail & Related papers  (2020-10-20T08:36:51Z)
• Learning To Navigate The Synthetically Accessible Chemical Space Using Reinforcement Learning [75.95376096628135]
  We propose a novel forward synthesis framework powered by reinforcement learning (RL) for de novo drug design. In this setup, the agent learns to navigate through the immense synthetically accessible chemical space. We describe how the end-to-end training in this study represents an important paradigm in radically expanding the synthesizable chemical space.
  arXiv  Detail & Related papers  (2020-04-26T21:40:03Z)
• The Synthesizability of Molecules Proposed by Generative Models [3.032184156362992]
  Discovery of functional molecules is an expensive and time-consuming process. One class of techniques of growing interest for early-stage drug discovery is de novo molecular generation and optimization. These techniques can suggest novel molecular structures intended to maximize a multi-objective function. However, the utility of these approaches is stymied by ignorance of synthesizability.
  arXiv  Detail & Related papers  (2020-02-17T15:41:28Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.